Gautier v. Celanese

143 F. Supp. 3d 429, 32 Am. Disabilities Cas. (BNA) 427, 2015 U.S. Dist. LEXIS 146038, 2015 WL 6511315
CourtDistrict Court, W.D. Virginia
DecidedOctober 28, 2015
DocketCase No. 7:14-cv-00621
StatusPublished
Cited by4 cases

This text of 143 F. Supp. 3d 429 (Gautier v. Celanese) is published on Counsel Stack Legal Research, covering District Court, W.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gautier v. Celanese, 143 F. Supp. 3d 429, 32 Am. Disabilities Cas. (BNA) 427, 2015 U.S. Dist. LEXIS 146038, 2015 WL 6511315 (W.D. Va. 2015).

Opinion

MEMORANDUM OPINION

MICHAEL F. URBANSKI, District Judge.

This case is an employment dispute involving an employee’s prescription drug [431]*431use. Plaintiff Jonathan Gautier (“Gautier”) claims that his employer, Celanese, violated the Americans with Disabilities Act (“ADA”) when it suspended him from work until he reduced his use of prescription pain medicine and self-enrolled in an Employee Assistance Program (“EAP”) for drug dependency. The dispute over Gautier’s suspension was previously submitted to arbitration pursuant to the collective-bargaining agreement (“CBA”) between Celanese and the Celanese Acetate & Workers United, Local 1995 (the “Union”). The preclusive effect of that arbitration is the sole issue raised by the parties.

Before the court is the defendants’ motion for summary judgment filed pursuant to Rule 56 of the Federal Rules of Civil Procedure, ECF No. 18, and Gautier’s motion to deny in part the motion for summary judgment pursuant to Rule 56(d) of the Federal Rules of Civil Procedure, ECF No. 20. The matter has been fully briefed, and the court heard oral argument on September 30, 2015. For the reasons set forth below, the court will not give preclu-sive effect to the arbitration decision and will thus DENY the defendants’ motion for summary judgment, ECF No. 18. The court also DENIES as moot Gautier’s motion to deny in part the motion for summary judgment, ECF No. 20.

I.

In 2002, Gautier suffered a serious 'injury at the Celanese plant while he was working in a mechanical lift that overturned.1 Compl., ECF No. 1, at ¶ 10. He returned to work six months later, and was employed at Celanese during all times relevant to this case until the company placed him on medical leave on May 23, 2013. Id. at ¶¶ 6, 8, 16. Gautier still suffers pain associated with his prior injury, and has been prescribed various pain medications since 2002. Id. In 2011, Celanese administered a drug test that discovered hydroco-done and Percocet in Gautier’s blood. Arbitration Decision, ECF No. 19-7, at 9. The company took no action because Gautier had prescriptions for both drugs and there was' no indication that the drugs affected his performance. Id.

On or about April 8, 2013, however, Ce-lanese supervisors noticed that Gautier appeared impaired during shifts. Id. One supervisor observed Gautier crushing and snorting pills at work. Id. Gautier also appeared tired, would bump into walls, and failed to maintain alertness. Id. at 10-12. When the behavior continued, the company restricted Gautier from work and sent him to get a medical evaluation. Id. at 12. The Union requested that Gautier not be drug tested, Celanese agreed, and the company instead put Gautier on medical leave, effective May 24, 2013. Id. at 12-13. The Union and Celanese also agreed that Gautier would benefit from an EAP drug rehabilitation course. Id. Gautier disputes that anyone told him to attend EAP. After being on medical leave for several weeks, Gautier received permission from his private doctors to return to work. Id. at 14-16. One of these doctors — Dr. Robert Devereaux — believed that Gautier’s drowsiness was caused by a combination of allergy pills and Gautier’s normal regimen of prescription pain medication. Id. at 14-15. Celanese claims that Dr. Devereaux’s opinion is flawed because Gautier was not forthright about the extent of his drug use.

Gautier returned to Celanese on July 15, 2013 with a work release effective July 20, 2013. Id. at 16. Gautier admitted he was taking Percocet, hydrocodone, and several [432]*432other medications, but claimed they were prescribed by his doctor. Id. Celanese administered a drug test, which showed Percocet and several other drugs in Gautier’s blood, but no hydrocodone. Id. at 16-17. Gautier provided a current prescription for hydrocodone and the other drugs, but could provide no prescription for Per-cocet. Id. Gautier later presented an expired Percocet prescription dated June 14, 2012, over a year prior to his positive drug test. Id. at 17. Dr. Kevin Soden, the medical director at Celanese, refused to clear Gautier to return to work. Id. at 18-19. Based on the combination of drugs Gautier was taking and his failure to provide a current prescription for Percocet, Dr. Soden believed Gautier had a drug problem. Id. The company refused to lift Gautier’s suspension until he reduced his use of narcotics and attended a rehabilitation program. Id.

Gautier filed a grievance through the Union, seeking clearance to return to work. At the same time, he filed the current complaint in federal court on November 12, 2014. The grievance was submitted to arbitration in December 2014 and January 2015, resulting in an arbitration decision favoring Celanese. The arbitrator found, among other things, that: (1) Gautier was suffering a serious work impairment in July 2013; (2) Gautier failed to inform his doctors about the full extent of his drug use; (3) Dr. Soden had a reasonable concern about Gautier’s ability to work safely; and (4) Gautier must attend a rehabilitation program before returning to work. Id. at 21-28.

Gautier has two claims before this court: (1) a failure to accommodate claim against Celanese under the ADA and (2) a state-law defamation claim against Celanese and Joseph Fox (“Fox”). The basis for the defamation claim is a letter sent by Fox, an employee of Celanese, to Gautier’s counsel that described Gautier as a “drug abuser,” stated he made other Celanese employees feel unsafe, and claimed that he failed to complete drug counseling.

II.

Pursuant to Federal Rule of Civil Procedure 56(a), the court must “grant summary judgment if the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R.Civ.P. 56(a); Celotex Corp. v. Catrett, 477 U.S. 317, 322, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986); Glynn v. EDO Corp., 710 F.3d 209, 213 (4th Cir.2013). When making this determination, the court should consider “the pleadings, depositions, answers to interrogatories, and admissions on file, together with ... [any] affidavits” filed by the parties. Celotex, 477 U.S. at 322, 106 S.Ct. 2548. Whether a fact is material depends on the relevant substantive law. Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986). “Only disputes over facts that might affect the outcome of the suit under the governing law will properly preclude the entry of summary judgment. Factual disputes that are irrelevant or unnecessary will not be counted.” Id. (citation omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
143 F. Supp. 3d 429, 32 Am. Disabilities Cas. (BNA) 427, 2015 U.S. Dist. LEXIS 146038, 2015 WL 6511315, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gautier-v-celanese-vawd-2015.